School personnel information

写真b

EGUCHI Hidetoshi


Keyword

Surgery, Oncology

Gender

Male

Organization 【 display / non-display

  • 2009.02.01 - 2010.03.31, Division of Surgical Medicine, Graduate School of Medicine, Assistant Professor

  • 2010.04.01 - 2010.09.30, Division of Surgical Medicine, Graduate School of Medicine, Assistant Professor

  • 2010.10.01 - 2014.12.31, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2015.01.01 - 2015.04.30, Division of Medicine, Graduate School of Medicine, Associate Professor

  • 2015.05.01 - 2019.11.30, Division of Medicine, Graduate School of Medicine, Associate Professor

  • 2019.12.01 - , Division of Medicine, Graduate School of Medicine, Professor

Education 【 display / non-display

Osaka University Faculty of Medicine  Graduated MD 1992.03
Osaka University Graduate School, Division of Medicine  Completed PhD 2000.03

Employment Record 【 display / non-display

Osaka University Hospital, Resident 1992.05 - 1993.06
Yao Municipal Hospital, Staff surgeon 1993.07 - 1996.03
Brown University, Postdoctoral fellow 2000.11 - 2003.06
Osaka Medical Center for Cancer and Cardiovascular Diseases 2003.07 - 2009.01
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University 2009.02 - 2010.03

Research topics 【 display / non-display

  • Gastroenterological Surgery
    Digestive surgery-related

 

Academic Papers 【 display / non-display

  • Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice., Tomohide Kurahashi, Yuichi Yoshida, Satoshi Ogura, Mayumi Egawa, Kunimaro Furuta, Hayato Hikita, Takahiro Kodama, Ryotaro Sakamori, Shinichi Kiso, Yoshihiro Kamada, I-Ching Wang, Hidetoshi Eguchi, Eiichi Morii, Yuichiro Doki, Masaki Mori, Vladimir V Kalinichenko, Tomohide Tatsumi, Tetsuo Takehara, Cellular and molecular gastroenterology and hepatology,9(3) 425-446, 2020.04, Other

  • Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function., Tomimaru Y, Eguchi H, Iwagami Y, Akita H, Noda T, Gotoh K, Kobayashi S, Nagano H, Mori M, Doki Y, Cancer chemotherapy and pharmacology,85(3) 537-545, 2020.03, Papers

  • Impact of CD36 on Chemoresistance in Pancreatic Ductal Adenocarcinoma., Kubo M, Gotoh K, Eguchi H, Kobayashi S, Iwagami Y, Tomimaru Y, Akita H, Asaoka T, Noda T, Takeda Y, Tanemura M, Mori M, Doki Y, Annals of surgical oncology,27(2) 610-619, 2020.02, Papers

  • Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinoma., Fukuda Y, Asaoka T, Eguchi H, Yokota Y, Kubo M, Kinoshita M, Urakawa S, Iwagami Y, Tomimaru Y, Akita H, Noda T, Gotoh K, Kobayashi S, Hirata M, Wada H, Mori M, Doki Y, Cancer science,111(2) 323-333, 2020.02, Papers

  • A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma., Eguchi H, Takeda Y, Takahashi H, Nakahira S, Kashiwazaki M, Shimizu J, Sakai D, Isohashi F, Nagano H, Mori M, Doki Y, Annals of surgical oncology,26(13) 4498-4505, 2019.12, Papers

display all >>